Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs

  • US 9,669,087 B2
  • Filed: 03/18/2015
  • Issued: 06/06/2017
  • Est. Priority Date: 12/29/2005
  • Status: Active Grant
First Claim
Patent Images

1. A method for preventing one or more of clinical symptoms associated with PCV2 infection, selected from the group consisting of:

  • PCV2 viral shedding, increased mortality rate, decreased average daily weight gain, and/or porcine circovirus load in piglets, said method comprising administering a single dose of a porcine circovirus type 2 ORF2 protein to a pig.

View all claims

    Thank you for your feedback